
Background
Carcinoma of cervix is the major malignancy of women. For cervical cancer diagnostics, there are about 55-million Pap smear tests performed every year in the United States. Pap smear screening for cervical cancer can result in 20% to 40% of false-negative results that lead to sometimes painful biopsies and put women at risk for pregnancy complications such as preterm labor and low-birth weight infants. Therefore there is a great need for a more accurate test of developmental stages of cervical cancers.
Technology Description
Src is a key molecule in oncogenesis and plays a major role in early development and progression of cervical and other types of cancer such as breast, colon, pancreatic, and lung. The novel biosensor developed by UCSD researchers combines FRET technology with genetically encoded biosensors which allows the monitoring of the Src tyrosine kinase activity in live cells, with high temporal and spatial resolutions. This innovation can potentially improve the sensitivity and accuracy for diagnosis of cervical cancer with Pap test samples.
Applications
- Diagnosis of cervical cancer with Pap test samples as well as other types of cancers
- Combining with a standard Pap test to reduce the false-negative rate of cervical cancer diagnosis
- Screening of new anticancer drug candidates against cervical cancer at different developmental stages
State Of Development
This technology has been further improved in the biosensor sensitivity, validated in cell culture and cervical biopsy samples.
Other Information
UCSD Researcher:
Dr. Chien, M.D., Ph.D., is University Professor and Director of the UCSD Whitaker Institute of Biomedical Engineering and former chair of the Jacobs School of Engineering’s, Department of Bioengineering.
Similar innovations
- Treatment of Cancer by Inducing Cell Apoptosis
- Synthetic polypeptides for treating and preventing diseases characterized by excess cell proliferation, such as mesenchymally derived cells.
- Read more
-
San Diego, CA, United States
- Diagnostic Test for Cancer Susceptibility
- The technology comprises diagnostic methods to detect mutations of the CDK4I gene as well as detecting deficiencies in the expression products of the gene. In addition, the technology also provides for the detection of mutations and altered gene product o
- Read more
-
San Diego, CA, United States
- Treatment of Liver Fibrosis by Induction of Stellate Cell Apoptosis
- An approach to the treatment of chronic liver disease based on an endogenous peptide targeting the stellate cells. Using standard delivery, the peptide triggers apoptosis only in the stellate liver cells responsible for liver fibrosis, but sparing hepatoc
- Read more
-
San Diego, CA, United States
- Methods of Tissue Repair, Regeneration, and Tissue Engineered Compositions
- A method of propagating ureteric bud (UB) cells in culture under conditions that induce the UB to undergo branching morphogenesis in order to generate a population of UB comprising tubular branches, subdividing the UB population, and resuspending each sub
- Read more
-
San Diego, CA, United States